Literature DB >> 10854253

Isolation and characterization of novel presenilin binding protein.

A Kashiwa1, H Yoshida, S Lee, T Paladino, Y Liu, Q Chen, R Dargusch, D Schubert, H Kimura.   

Abstract

Approximately 50% of familial Alzheimer's disease (AD) cases are linked to the presenilin (PS) gene. This suggests that an altered function of mutated PSs accounts for a fundamental process leading to AD. Here we identify a new PS binding protein, PBP, which is highly expressed in cerebral cortex and hippocampus. immunohistochemical studies and cell fractionation analysis show that PBP redistributes from cytoplasm to membranes in the presence of PS. In addition, PBP is deficient in the soluble fraction of sporadic AD brains.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854253     DOI: 10.1046/j.1471-4159.2000.0750109.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  26 in total

1.  Variants in DOCK3 cause developmental delay and hypotonia.

Authors:  Kimberly Wiltrout; Alejandro Ferrer; Ingrid van de Laar; Kazuhiko Namekata; Takayuki Harada; Eric W Klee; Michael T Zimmerman; Margot A Cousin; Jennifer L Kempainen; Dusica Babovic-Vuksanovic; Marjon A van Slegtenhorst; Coranne D Aarts-Tesselaar; Rhonda E Schnur; Marisa Andrews; Marwan Shinawi
Journal:  Eur J Hum Genet       Date:  2019-04-11       Impact factor: 4.246

Review 2.  Reversing synapse loss in Alzheimer's disease: Rho-guanosine triphosphatases and insights from other brain disorders.

Authors:  Roger Lefort
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

3.  DOCK3-related neurodevelopmental syndrome: Biallelic intragenic deletion of DOCK3 in a boy with developmental delay and hypotonia.

Authors:  Aiko Iwata-Otsubo; Alyssa L Ritter; Brooke Weckselbatt; Nicole R Ryan; David Burgess; Laura K Conlin; Kosuke Izumi
Journal:  Am J Med Genet A       Date:  2017-11-12       Impact factor: 2.802

4.  Presenilin binding protein is associated with neurofibrillary alterations in Alzheimer's disease and stimulates tau phosphorylation.

Authors:  Q Chen; H Yoshida; D Schubert; P Maher; M Mallory; E Masliah
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

5.  Dock3 attenuates neural cell death due to NMDA neurotoxicity and oxidative stress in a mouse model of normal tension glaucoma.

Authors:  K Namekata; A Kimura; K Kawamura; X Guo; C Harada; K Tanaka; T Harada
Journal:  Cell Death Differ       Date:  2013-07-12       Impact factor: 15.828

6.  Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon.

Authors:  M R López-Huertas; S Callejas; D Abia; E Mateos; A Dopazo; J Alcamí; M Coiras
Journal:  Nucleic Acids Res       Date:  2010-02-05       Impact factor: 16.971

7.  Disruption of a novel member of a sodium/hydrogen exchanger family and DOCK3 is associated with an attention deficit hyperactivity disorder-like phenotype.

Authors:  M G de Silva; K Elliott; H-H Dahl; E Fitzpatrick; S Wilcox; M Delatycki; R Williamson; D Efron; M Lynch; S Forrest
Journal:  J Med Genet       Date:  2003-10       Impact factor: 6.318

8.  Proteasome-mediated effects on amyloid precursor protein processing at the gamma-secretase site.

Authors:  Fiona Flood; Suzanne Murphy; Richard F Cowburn; Lars Lannfelt; Brian Walker; Janet A Johnston
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

9.  Loss of modifier of cell adhesion reveals a pathway leading to axonal degeneration.

Authors:  Qi Chen; Charles A Peto; G Diane Shelton; Andrew Mizisin; Paul E Sawchenko; David Schubert
Journal:  J Neurosci       Date:  2009-01-07       Impact factor: 6.167

10.  A novel functional screen in human cells identifies MOCA as a negative regulator of Wnt signaling.

Authors:  Elanite Caspi; Rina Rosin-Arbesfeld
Journal:  Mol Biol Cell       Date:  2008-08-20       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.